These guidelines are a summary derived from national and international guidelines.1–7
By: J. De Grève MD, PhD, M. Peeters MD, PhD, V. Remouchamps MD, PhD, Y. Lievens MD, PhD, M. Lambrecht MD, PhD
These guidelines are a summary derived from national and international guidelines.1–7
* (only possible for healthcare professionals with RIZIV/INAMI/MATRICULE working in the field of Oncology/Hemato-oncology in Belgium and Luxembourg with prescription authorisation)
** (for healthcare professionals with prescribing authorisation working outside the field of Oncology/Hemato-oncology in Belgium and Luxembourg as well as those without prescribing authorisation working as healthcare professional in Oncology/Hemato-oncology in Belgium and Luxembourg, plus persons without prescription authorisation working outside Belgium and Luxembourg, plus healthcare professionals with prescribing authorisation outside Belgium and Luxembourg plus non-healthcare professionals from outside or inside Belgium or Luxembourg)
Top
